Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Axcan Pharma; the next biochempharma ?? -- Ignore unavailable to you. Want to Upgrade?

To: Marc Fortier who wrote (3)	2/12/1999 1:26:00 AM
From: Marc Fortier	Respond to of 4

Well, I thought that it might be a good idea to reactivate this thread, more than one year after I posted the last message... Lot's of good things happened to Axcan meanwhile. Urso was finally accepted by the FDA. It has been awarded the orphan drug status for the treatment of a rare and fatal liver disease. Since then, Axcan's revenues have gone up sharply. Now may be the time to jump in the boat, since the company will probably begin to show a good increase in earnings in the next few quarters. MF